ezlopitant has been researched along with moxifloxacin in 1 studies
| Studies (ezlopitant) | Trials (ezlopitant) | Recent Studies (post-2010) (ezlopitant) | Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) |
|---|---|---|---|---|---|
| 22 | 2 | 1 | 3,157 | 552 | 1,690 |
| Protein | Taxonomy | ezlopitant (IC50) | moxifloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Staphylococcus aureus | 5.1033 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 1.4 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 1.4 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.8 | |
| DNA gyrase subunit A | Staphylococcus aureus | 7.25 | |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 8.525 | |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 8.66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
1 other study(ies) available for ezlopitant and moxifloxacin
| Article | Year |
|---|---|
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |